Real-world evaluation of a two-step testing algorithm for Clostridioides difficile infection

During the 4 years after implementation of the 2-step Clostridioides difficile infection (CDI) testing algorithm, 70% to 78% of patients with suspected CDI and a positive nucleic acid amplification test but a negative toxin test (NAAT+/TOX−) received CDI treatment. Overall, 73% of NAAT+/TOX− patient...

Full description

Saved in:
Bibliographic Details
Published inInfection control and hospital epidemiology Vol. 44; no. 9; pp. 1494 - 1496
Main Authors Hecker, Michelle T., Son, Andrea H., Zuccaro, Patricia, Conti, Jennifer, Donskey, Curtis J.
Format Journal Article
LanguageEnglish
Published New York, USA Cambridge University Press 01.09.2023
Subjects
Algorithms
Antibiotics
Asymptomatic
Blood
Chemotherapy
Concise Communication
Creatinine
Enzymes
Immunoassay
Infections
Laxatives
Leukocytes
Medical records
Mortality
Nucleic acids
Patients
Toxins
Online AccessGet full text

Cover

More Information
Summary:During the 4 years after implementation of the 2-step Clostridioides difficile infection (CDI) testing algorithm, 70% to 78% of patients with suspected CDI and a positive nucleic acid amplification test but a negative toxin test (NAAT+/TOX−) received CDI treatment. Overall, 73% of NAAT+/TOX− patients were classified as having probable or possible CDI.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0899-823X
1559-6834
DOI:10.1017/ice.2022.313